Illumina, Inc. Announces Mitsubishi Chemical Safety Institute as Japan’s First Certified Genetic Analysis Service Provider

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc., (NASDAQ:ILMN) today announced that Mitsubishi Chemical Safety Institute, a provider of various analyses, examinations, and services for pharmaceutical companies, public institutions, and chemical companies, is the first organization in Japan to become an Illumina CSPro® (certified service provider). Illumina CSPro is a collaborative service provider partnership dedicated to ensuring the delivery of the highest-quality data available for genetic analysis applications. Mitsubishi Chemical Safety Institute offers its customers whole-genome and targeted-genotyping services using Illumina’s Infinium® and GoldenGate® Assays. Both assays leverage Illumina’s proprietary BeadArray® technology to provide customers the ability to perform large-scale interrogation of the human genome, which enables them to cost-effectively fast forward their research and identify genetic variants linked to disease.